CAR T-Cell Therapy For Multiple Myeloma – Michael's Story – Nebraska Medicine After conventional treatments weren’t effective, Michael Cox became our first patient to take part in a clinical trial for CAR T-cell therapy for multiple myeloma. Learn more in this brief video about how the treatment works and why his doctor is hopeful this […]
Read More
”; This is a question that many doctors and medical researcher are searching for in their science laboratories and research centers. Every field thinks that they have discovered the cause of disease. And, indeed cause of a disease has many steps and its important not to explain the cause of disease at an intermediate step. […]
Read More ”; Gum disease, also known as gingivitis, is a serious condition that will normally result in tooth loss. With adults, gingivitis and periodontal disease are the most common forms of gum disease. To prevent both types of gum disease, you should always brush your teeth and remove as much plaque as possible. If you allow […]
Read More Golf Pro Sues Monsanto, Claims Roundup Caused Cancer By James Parker A Washington state golf pro who says exposure to Roundup caused his cancer has filed a lawsuit against Monsanto. The suit comes just months after German agricultural and pharmaceutical giant Bayer, which bought Monsanto in 2018, agreed to settle thousands of similar Roundup cancer […]
Read More
Meta-analysis of Duration of Adjuvant Trastuzumab in Early Breast Cancer By Matthew StengerPosted: 9/16/2020 11:39:00 AM Last Updated: 9/16/2020 2:09:15 PM Advertisement In individual participant data and trial-level meta-analyses reported in JAMA Network Open, Gulia et al found that disease-free survival with adjuvant trastuzumab given for less than 1 year was noninferior to 1 year […]
Read More
Breakthrough discovery could turn cancer into a treatable disease Reviewed by Emily Henderson, B.Sc.Sep 16 2020 Professor Michael Lisanti and Professor Federica Sotgia have made a discovery that could turn cancer into a treatable disease and remove the fear from a cancer diagnosis. Despite years of research and billions of pounds of investment, there are […]
Read More
Novel Agents Rouse Responses in Relapsed/Refractory Multiple Myeloma In just the past 5 years, incredible progress has been made in multiple myeloma, evidenced by the emergence of novel CD38 antibodies, BCMA-directed treatments, and cereblon E3 ligase modulators (CELMoDs), according to Thomas G. Martin, MD. “We have a lot of options that are coming up. It’s […]
Read More